Skip to main content
. 2023 Nov 7;36:11963. doi: 10.3389/ti.2023.11963

FIGURE 2.

FIGURE 2

Potential uses of CMV-CMI assays in CMV-seropositive patients according to preventive strategy and use of T-cell depleting antibodies.